Actively Recruiting

Age: 18Years +
FEMALE
Healthy Volunteers
ID06392997

Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology

Led by ZIWIG · Updated on 2025-01-23

2500

Participants Needed

13

Research Sites

N/A

Total Duration

On this page

Sponsors

Z

ZIWIG

Lead Sponsor

M

Monitoring Force Group

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are conducting an international non-interventional study to identify diagnostic markers for gynecological diseases by analyzing coding and non-coding RNA in saliva samples. The study focuses on symptomatic females with gynecological conditions such as endometriosis, adenomyosis, ovarian cysts, fibroids, and gynecological cancers, as well as asymptomatic females. Participants will continue their usual medical care without changes to treatment or diagnostic procedures. Participants are grouped into symptomatic females who have one or more specified gynecological pathologies and asymptomatic females either with cervical dysplasia or cancer or with normal pap-smears as controls. The study involves collecting saliva samples to analyze RNA content as a diagnostic tool. Patients will undergo their planned surgeries or biopsies according to standard care. During the study, participants will provide saliva samples and have their clinical status recorded. Researchers will measure the diagnostic accuracy of RNA markers by evaluating the area under the curve (AUC) of a receiver operating characteristic (ROC) curve over about one year. No additional treatment changes or interventions will be made. The total participation duration depends on the timing of scheduled surgeries and follow-ups.

CONDITIONS

Brief Title

Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology

Who Can Participate

Age: 18Years +
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Female aged 18 years or older
  • Signed informed consent
  • Has medical insurance
  • Symptomatic with one or more of: endometriosis, adenomyosis, ovarian cysts, fibroids, ovarian cancer, cervical cancer, uterine cancer and scheduled for diagnostic surgery or biopsy
  • Asymptomatic with positive pap smear for cervical dysplasia or cervical cancer before treatment
  • Asymptomatic undergoing pap smear for cervical cancer screening
Not Eligible

You will not qualify if you...

  • Recent (less than 1 month) or ongoing bacterial or viral infection
  • Active oral or digestive fungal infection
  • Current symptomatic or obvious oral disease
  • Known pregnancy
  • Known current non-gynecological pelvic pathology
  • Diagnosed breast cancer or non-gynecological cancer except basal cell carcinoma
  • History of treated cancer within last 5 years except basal cell carcinoma
  • Prior chemotherapy, radiotherapy, or surgery for the gynecological pathology included
  • Significant difficulties reading or writing the language
  • Unable to comply with study or follow-up procedures
  • Participation in another interventional study or within exclusion period

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Up to 1 year

Participants provide saliva samples to evaluate salivary RNA related to gynecologic pathology before surgery or biopsy.

1 or more visits depending on group assignment

Surgery and Immediate Post-operative Care

Duration - Up to 1 week

Participants undergo diagnostic surgery or biopsy for their gynecologic pathology as part of routine care.

1 surgical procedure with immediate post-operative care

Long-term Monitoring

Duration - Up to 1 year

Participants are observed for outcomes related to their gynecologic condition after surgery or biopsy, including follow-up saliva sample assessments.

Periodic follow-up visits over the year

Trial Site Locations

Total: 13 locations

1

CHU d'Angers

Angers, France

Not Yet Recruiting

2

Clinique Tivoli Ducos - IFEMENDO

Bordeaux, France

Actively Recruiting

3

Institut Bergonié

Bordeaux, France

Not Yet Recruiting

4

CHU Caen

Caen, France, 14033

Actively Recruiting

5

CGFL

Dijon, France

Not Yet Recruiting

6

CHU Lyon Sud

Lyon, France

Not Yet Recruiting

7

American Hospital of Paris

Neuilly-sur-Seine, France

Not Yet Recruiting

8

CHU de Rennes Site Hôpital Sud

Rennes, France

Not Yet Recruiting

9

Clinique La sagesse

Rennes, France

Not Yet Recruiting

10

CHU Rouen

Rouen, France

Actively Recruiting

11

Clinique Pasteur

Toulouse, France

Actively Recruiting

12

CHU Bretonneau-Tours

Tours, France

Actively Recruiting

13

Institut Gustave Roussy

Villejuif, France

Not Yet Recruiting

Loading map...

Research Team

S

Sofiane Bendifallah, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

Metabolic Tracing of Tumour and T Cells in the Ascites of Ov...

Ovarian Cancer

Actively Recruiting

1 location

A Phase 1/2a Study of the Safety, Tolerability, and Prelimin...

Castration-Resistant Prostate Cancer (CRPC)

Actively Recruiting

4 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here